Literature DB >> 26369981

Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification.

G Michel1, R Cunha2, A Ruggeri2,3, T A O'Brien4, H Bittencourt5, J H Dalle6, F Locatelli7, A P Iori8, M Mauad9, C Oudin1, F Giannotti2,3, F Volt2, E Gluckman2,10, P Bader11, V Rocha2,12.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26369981     DOI： 10.1038/leu.2015.243

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.

Authors:  A Sander; M Zimmermann; M Dworzak; G Fleischhack; C von Neuhoff; D Reinhardt; G J L Kaspers; U Creutzig
Journal:  Leukemia       Date:  2010-06-10       Impact factor: 11.528

2.  The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.

Authors:  Jan-Henning Klusmann; Dirk Reinhardt; Martin Zimmermann; Bernhard Kremens; Josef Vormoor; Michael Dworzak; Ursula Creutzig; Thomas Klingebiel
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

Authors:  Christine J Harrison; Robert K Hills; Anthony V Moorman; David J Grimwade; Ian Hann; David K H Webb; Keith Wheatley; Siebold S N de Graaf; Eva van den Berg; Alan K Burnett; Brenda E S Gibson
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

4.  Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

Authors:  Christine von Neuhoff; Dirk Reinhardt; Annette Sander; Martin Zimmermann; Jutta Bradtke; David R Betts; Zuzana Zemanova; Jan Stary; Jean-Pierre Bourquin; Oskar A Haas; Michael N Dworzak; Ursula Creutzig
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

5.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

6.  t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.

Authors:  Julie Damgaard Sandahl; Eva A Coenen; Erik Forestier; Jochen Harbott; Bertil Johansson; Gitte Kerndrup; Souichi Adachi; Anne Auvrignon; H Berna Beverloo; Jean-Michel Cayuela; Lucy Chilton; Maarten Fornerod; Valérie de Haas; Christine J Harrison; Hiroto Inaba; Gertjan J L Kaspers; Der-Cherng Liang; Franco Locatelli; Riccardo Masetti; Christine Perot; Susana C Raimondi; Katarina Reinhardt; Daisuke Tomizawa; Nils von Neuhoff; Marco Zecca; C Michel Zwaan; Marry M van den Heuvel-Eibrink; Henrik Hasle
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

7.  Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

Authors:  Henrik Hasle; Todd A Alonzo; Anne Auvrignon; Catherine Behar; Myron Chang; Ursula Creutzig; Alexandra Fischer; Erik Forestier; Alcira Fynn; Oskar A Haas; Jochen Harbott; Christine J Harrison; Nyla A Heerema; Marry M van den Heuvel-Eibrink; Gertjan J L Kaspers; Franco Locatelli; Peter Noellke; Sophia Polychronopoulou; Yaddanapudi Ravindranath; Bassem Razzouk; Dirk Reinhardt; Natalia N Savva; Batia Stark; Stefan Suciu; Ichiro Tsukimoto; David K Webb; Dorora Wojcik; William G Woods; Martin Zimmermann; Charlotte M Niemeyer; Susana C Raimondi
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Allo-SCT using BU, CY and melphalan for children with AML in second CR.

Authors:  R Beier; M H Albert; P Bader; A Borkhardt; U Creutzig; M Eyrich; K Ehlert; B Gruhn; J Greil; R Handgretinger; W Holter; T Klingebiel; B Kremens; P Lang; C Mauz-Körholz; R Meisel; I Müller; C Peters; D Reinhardt; P Sedlacek; A Schulz; F R Schuster; A Schrauder; B Strahm; K W Sykora; W Wössmann; M Zimmermann; M G Sauer
Journal:  Bone Marrow Transplant       Date:  2012-10-29       Impact factor: 5.483

Review 10.  Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.

Authors:  Gerard Michel; Vanderson Rocha; Sylvie Chevret; William Arcese; Kah-Wah Chan; Alexandra Filipovich; Tsuneo A Takahashi; Marcus Vowels; Juan Ortega; Pierre Bordigoni; Peter J Shaw; Isaac Yaniv; Alexandra Machado; Pedro Pimentel; Franca Fagioli; Amparo Verdeguer; Jean Pierre Jouet; Blanca Diez; Euripedes Ferreira; Ricardo Pasquini; Joseph Rosenthal; Eric Sievers; Chiara Messina; Anna Paola Iori; Federico Garnier; Irina Ionescu; Franco Locatelli; Eliane Gluckman
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113
View more
  2 in total

1.  Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.

Authors:  A-L Alloin; G Leverger; J-H Dalle; C Galambrun; Y Bertrand; A Baruchel; A Auvrignon; V Gandemer; C Ragu; A Loundou; C Bilhou-Nabera; M Lafage-Pochitaloff; N Dastugue; B Nelken; C Jubert; F Rialland; G Plat; C Pochon; J-P Vannier; P-S Rohrlich; J Kanold; P Lutz; A Sirvent; C Oudin; W Cuccuini; G Michel
Journal:  Bone Marrow Transplant       Date:  2016-12-12       Impact factor: 5.483

2.  Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.

Authors:  Joy Benadiba; Marc Ansari; Maja Krajinovic; Marie-France Vachon; Michel Duval; Pierre Teira; Sonia Cellot; Henrique Bittencourt
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.